Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEPS3: Teduglutide Extension in Short Bowel Syndrome
NCT01560403Phase 3Completed
- Sponsor
- Takeda
- Start
- May 2012
- Primary completion
- Jul 2013
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of teduglutide in short bowel syndrome (SBS), sponsored by Takeda. Started May 2012; status: completed.
02
Drugs
teduglutide
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on NCT01560403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01560403.